Amiodarone-Induced Thyrotoxicosis
Authors:
- Stefan BilzSBStefan Bilz
- Christian SticherlingCSChristian Sticherling
- Stefan OsswaldSOStefan Osswald
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial FibrillationArchives of internal medicine (1960), 2006
- Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter DefibrillatorsThe OPTIC Study: A Randomized TrialJAMA, 2006
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Treatment of Type II Amiodarone-Induced Thyrotoxicosis by Either Iopanoic Acid or Glucocorticoids: A Prospective, Randomized StudyThe Journal of Clinical Endocrinology & Metabolism, 2003
- Oral Cholecystographic Agents and the ThyroidThe Journal of Clinical Endocrinology & Metabolism, 2001
- Amiodarone-Induced ThyrotoxicosisThe Journal of Clinical Endocrinology & Metabolism, 2001
- Amiodarone to Prevent Recurrence of Atrial FibrillationNew England Journal of Medicine, 2000
- Adverse Effects of Low Dose Amiodarone: A Meta-AnalysisJACC, 1997
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Amiodarone: Electrophysiologic actions, pharmacokinetics and clinical effectsJACC, 1984